MHC-Antigen Peptide Fusion Proteins (Altor)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMHC-Antigen Peptide Fusion Proteins (Altor)
Drug Alias NameIMPACT therapeutics (Altor)major histocompatibility complex-peptide fusion proteins (Altor)MHC-antigen peptide fusion proteins (Altor)
ClassificationBiologics > AntigenBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionHuman leukocyte antigen inhibitors
TargetsHuman leukocyte antigen
Therapy Area/IndicationsAutoimmune DiseasesDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAltor Bioscience Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAltor Bioscience Corp
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A